Synopsis
Synopsis
0
USDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Equilium
2. Flo 1347
3. Flo-1347
4. Flo1347
5. Hydrochloride, Tiapride
6. Monohydrochloride, Tiapride
7. Tiapridal
8. Tiapride
9. Tiapride Monohydrochloride
10. Tiapridex
11. Tiaprizal
1. 51012-33-0
2. Tiapride Hcl
3. Tiapridal
4. Tiapride (hydrochloride)
5. Gramalil
6. Italprid
7. Luxoben
8. Sereprile
9. Tiapridex
10. Tiapridehydrochloride
11. Mls000069678
12. N-[2-(diethylamino)ethyl]-5-(methylsulfonyl)-o-anisamide Hydrochloride
13. Tiapride Hydrochloride [jan]
14. Benzamide, N-[2-(diethylamino)ethyl]-2-methoxy-5-(methylsulfonyl)-,monohydrochloride
15. Smr000058514
16. Dsstox_cid_25210
17. Dsstox_rid_80753
18. Dsstox_gsid_45210
19. N-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)benzamide Hydrochloride
20. 25n106wedo
21. Sr-01000000232
22. Ncgc00015996-02
23. Cas-51012-33-0
24. N-(2-[diethylamino]ethyl)-5-(methylsulfonyl)-o-anisamide Hydrochloride
25. N-[2-(diethylamino)ethyl]-2-methoxy-5-(methylsulfonyl)benzamide Hydrochloride
26. Gramalil (tn)
27. Prestwick_580
28. Mfcd00133861
29. Benzamide, N-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)-, Monohydrochloride
30. Opera_id_408
31. Tiapride Hydrochloride,(s)
32. Mls001076118
33. Schembl355315
34. Spectrum1503086
35. Tiapride Hydrochloride (jp17)
36. Chembl1256772
37. Dtxsid4045210
38. Chebi:32220
39. Hms1568l13
40. Hms1922e05
41. Pharmakon1600-01503086
42. Tiapride Hydrochloride [mi]
43. Bcp13379
44. Hy-b1196
45. Tox21_110276
46. Tox21_501124
47. Ccg-39299
48. Nsc758225
49. Akos015891372
50. Tiapride Hydrochloride [mart.]
51. Tox21_110276_1
52. Ab03720
53. Cs-4804
54. Hs-0005
55. Lp01124
56. Tiapride Hydrochloride [who-dd]
57. Ncgc00015996-10
58. Ncgc00094392-01
59. Ncgc00094392-02
60. Ncgc00094392-03
61. Ncgc00094392-04
62. Ncgc00094392-05
63. Ncgc00261809-01
64. Bt166255
65. Eu-0101124
66. Ft-0630638
67. S9509
68. T3600
69. Tiapride Hydrochloride [ep Monograph]
70. D01522
71. T 0410
72. T72548
73. Sr-01000000232-2
74. Sr-01000000232-6
75. Q27253983
76. N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide,hydrochloride
77. Benzamide, N-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)-, Hydrochloride (1:1)
Molecular Weight | 364.9 g/mol |
---|---|
Molecular Formula | C15H25ClN2O4S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 364.1223562 g/mol |
Monoisotopic Mass | 364.1223562 g/mol |
Topological Polar Surface Area | 84.1 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 443 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Certificate Number : CEP 2018-066 - Rev 01
Issue Date : 2024-04-19
Type : Chemical
Substance Number : 1575
Status : Valid
Available Reg Filing : ASMF |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R1-CEP 2002-113 - Rev 03
Issue Date : 2014-04-03
Type : Chemical
Substance Number : 1575
Status : Valid
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
Certificate Number : R1-CEP 2014-274 - Rev 00
Issue Date : 2020-01-16
Type : Chemical
Substance Number : 1575
Status : Valid
Registration Number : 218MF10085
Registrant's Address : Via Delle Arti 33, 20049 Concorezzo (MI), Italy
Initial Date of Registration : 2006-01-27
Latest Date of Registration : --
Registration Number : 217MF10714
Registrant's Address : 1-10-11, Nihonbashi Horidomecho, Chuo-ku, Tokyo
Initial Date of Registration : 2005-10-07
Latest Date of Registration : --
Registration Number : 226MF10077
Registrant's Address : 1-10-11, Nihonbashi Horidomecho, Chuo-ku, Tokyo
Initial Date of Registration : 2014-04-02
Latest Date of Registration : --
Registration Number : 222MF10276
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2010-12-17
Latest Date of Registration : --
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tiapride Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiapride Hydrochloride, including repackagers and relabelers. The FDA regulates Tiapride Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiapride Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiapride Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiapride Hydrochloride supplier is an individual or a company that provides Tiapride Hydrochloride active pharmaceutical ingredient (API) or Tiapride Hydrochloride finished formulations upon request. The Tiapride Hydrochloride suppliers may include Tiapride Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Tiapride Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tiapride Hydrochloride Drug Master File in Japan (Tiapride Hydrochloride JDMF) empowers Tiapride Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tiapride Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Tiapride Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tiapride Hydrochloride suppliers with JDMF on PharmaCompass.
A Tiapride Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Tiapride Hydrochloride Certificate of Suitability (COS). The purpose of a Tiapride Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tiapride Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tiapride Hydrochloride to their clients by showing that a Tiapride Hydrochloride CEP has been issued for it. The manufacturer submits a Tiapride Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tiapride Hydrochloride CEP holder for the record. Additionally, the data presented in the Tiapride Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tiapride Hydrochloride DMF.
A Tiapride Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tiapride Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tiapride Hydrochloride suppliers with CEP (COS) on PharmaCompass.
Tiapride Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiapride Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiapride Hydrochloride GMP manufacturer or Tiapride Hydrochloride GMP API supplier for your needs.
A Tiapride Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Tiapride Hydrochloride's compliance with Tiapride Hydrochloride specifications and serves as a tool for batch-level quality control.
Tiapride Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Tiapride Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiapride Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiapride Hydrochloride EP), Tiapride Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiapride Hydrochloride USP).
LOOKING FOR A SUPPLIER?